SANO

Sano is developing a Point of Care diagnostic platform to early detect and intervene in at least 6 different diseases affecting human and vet populations. Their first focus is human chronic wounds, such as diabetic foot ulcers and venous​​ leg ulcers, personalizing treatment to promote faster healing and avoid over $3B in treatment costs from trial and error and prolonged chronicity. They have tested their proprietary chemistry, have prototypes designed, and soon will start clinical trials and submit for regulatory clearance.